Estrogen has been postulated as a contributor for lung cancer development and
progression. We reviewed the current knowledge about the expression and prognostic …

Lung cancer mortality represents the leading cause of cancer related deaths in the United
States and worldwide. Almost half of these deaths occur in female patients, making lung …

Lung cancer (LC) is the leading cause of cancer death in men worldwide and has
significantly increased in women. Differences in non-small cell lung cancer (NSCLC) …

Purpose: To determine the frequency of estrogen receptor α and β and progesterone
receptor protein immunohistochemical expression in a large set of non–small cell lung …

Increasing evidence indicates that estrogen promotes tumor growth in both estrogen target
organs and non-target organs. Estrogen regulates cell proliferation and differentiation via …

It is becoming increasingly clear that steroid hormones are involved in the biology of many
organs outside the reproductive system. Evidence has been accumulating since the mid …

Lung cancer incidence and mortality have significantly increased in women worldwide. Lung
adenocarcinoma is the most common form of lung cancer globally. This type of lung cancer …

Introduction Treatment with epidermal growth factor receptor (EGFR) tyrosine kinase
inhibitors (TKIs) yields tumour responses in non-small cell lung cancer (NSCLC) patients …

Immunostaining for thyroid transcription factor-1 (TTF-1) is frequently used to help assess
the site of origin of metastatic carcinomas. TTF-1 expression is most frequently seen in …

Historically, lung cancer has been viewed as a male disease, but during the past 50 years
there has been a dramatic increase in the incidence of lung cancer in women. Lung cancer …